• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

AAFP Urges CMS to Delay Meaningful Use Stage 2 Compliance by 12 Months

by Fred Pennic 08/14/2013 6 Comments

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

The American Academy of Family Physicians (AAFP), which represents more than 110,600 family physicians and medical students nationwide and its Center for Health Information Technology recently made an appeal to CMS “not to delay the implementation of MU Stage 2 but to extend the timeframe for compliance with MU Stage 2 requirements by 12 months.”

In the letter sent on August 7th to CMS Administrator Marilyn Tavenner, MS, AAFP Board Chair Glen Stream, M.D., M.B.I. said,

AAFP Urges CMS to Delay Meaningful Use Stage 2 Compliance by 12 Months
AAFP Board Chair Glen Stream, M.D., M.B.I

“We are increasingly concerned that the regulatory expectations of MU Stage 2 and its current timeframe will outstrip the capacity of many certified electronic health record technology (CEHRT) vendors and ambulatory family medicine practices. We agree conceptually with a staged approach to enhanced care safety, quality, coordination, patient engagement, and population health through the effective implementation and use of health information technology (IT). However, 2014 brings a perfect storm of regulatory compliance issues for family physicians that, we fear, may derail health IT adoption and substantially interfere with our shared progress toward achieving better care for patients, better health for communities, and lower costs through improvements to the health care system.

AAFP’s main concern is that members will fail to obtain the products, implementations, services, training and support required to successfully meet Meaningful Use stage 2 deadlines set by CMS and the ONC.

“Though we do not wish to impede the progress of early adopter physicians poised for MU stage two on Jan. 1, 2014, we do not wish to see other family physicians who have committed to health care transformation through the thoughtful application of health IT abandon the MU journey due to factors beyond their control,” said Stream.

Also in the letter, Stream outlines an AAFP proposal that would advance the priorities of meaningful use while at the same time maintaining the current momentum of health care transformation.

The four-color proposal illustration shows how AAFP’s Meaningful Use stage 2 extension proposal would meter 2014 CEHRT upgrade demand while simultaneously maintaining the current momentum of healthcare transformation.

The proposed timeline change would create three distinct cohorts of physicians and other eligible professionals, each of which would be affected differently by the modified schedule. In his letter, Stream outlined the requirements for each of the three groups:

  • cohort one would include physicians who attest to MU in 2014 as their first payment year and who then would follow a specific timeline for MU reporting to receive a bonus payment;
  • cohort two would include physicians attesting to MU in 2014 as their second payment year, and they would follow a separate set of EHR upgrade and reporting period guidelines to receive a 2015 bonus payment; and
  • cohort three would include physicians attesting to MU in 2014 as their third or fourth payment year. This group also would have to comply with specific EHR upgrade and reporting period guidelines, and qualifying physicians would receive both their 2014 and 2015 MU bonus payments.

According to Stream, “this modified timeline would allow exemplar practices to implement MU stage two requirements early in 2014.”

“Pressure would be kept on vendors to be ready for MU stage two by Jan. 1, 2014, while distributing the strain of conversion of vendor product and physician workflow over a 21-month period rather than a nine-month period,” said Stream.

  • Read the letter to CMS & ONC here
  • Read official AAFP announcement here
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |